Pharmacy Podcast Network

Review of MDMA and LSD, intro to psilocybin | Neural Pharm Podcast

In this episode Colby reviews his experiences at the MAPS conference in Denver, we review a couple of topics we missed around LSD and MDMA, and introduce psilocybin!
 
References:
Gotvaldova K, et al. "Extensive Collection of Psychotropic Mushrooms with Determination of Their Tryptamine Alkaloids". International Journal of Molecular Sciences. 2023 (22): 14068.
Halpern J, Roth BL "Hallucinogens and dissociative agents naturally growing in the United States". Pharmacology & Therapeutics. 2004; 102 (2): 131–8.
Huberman A. The science of MDMA and its therapeutic uses: benefits and risks. Huberman Labs (podcast). 12 Jun 2023
Pollan M. How to change your mind: the new science of psychedelics. Penguin Press. 2019
Sumner R, et al. Microdosed LSD: Dose day outcomes from a home-administered randomized controlled trial. 2023. Unpublished (information from poster presentation at MAPS conference)
Woolley DW, Campbell NK (1962). "Serotonin-like and antiserotonin properties of psilocybin and psilocin". Science. 3518. 136 (3518): 777–8
Vizeli P, et al. Genetic influence of Cyp2D6 on pharmacokinetics and acute subjective effects of LSD in a pooled analysis. Scientific Reports. 2021(11); 10851.

How Can Innovation Unlock the Power of Data to Deliver Value-Based Care? | Pharmacy Podcast Nation

Pamela SpenceEY Global Health Sciences and Wellness Industry Leader Organizations have the tools to deliver a better personalized health experience, but the ecosystem needs to collaborate to build this future.
Three questions to ask
How can placing bigger bets, and making strategic investments that go beyond pilot initiatives, achieve transformation at scale?
How do organizations collaborate to share risk, data and rewards and realize a better future?
How do we move from a slowly digitizing world to connected care and ultimately to a smart health system?
References:EY survey: 42% of global health consumers rate access to care as below averagehttps://www.ey.com/en_gl/news/2023/06/ey-survey-42-of-global-health-consumers-rate-access-to-care-as-below-averageHow innovation can unlock the power of data to deliver value-based carehttps://www.ey.com/en_gl/life-sciences/how-innovation-can-unlock-the-value-of-data-to-deliver-value-based-care?linkId=206400904 
New boost

TWIRx | Leveling UP with UP Solutions & Global Leaders in Digital Health

On "This Week in Pharmacy" Todd Eury talks with the leading Digital Health Pharmacist in New Zealand Katrina Azer about the rising useage of technology as part of treatment plans in pharmacy care. Next, a special conversation with Community Pharmacy Business Coach of the Coaches, Patti Mara --who came from the PDS strategy team helping pharmacy leaders like Lisa Faast launch successful enterprises.

Examining Patient Burden in Atopic Dermatitis: Understanding Treatment Barriers and Optimal Use of OTC Skin Care Products, featuring a Caregiver Perspective | PTCE Pharmacy Connect

To claim CE credit for this activity, please follow this link: www.pharmacytimes.org/atopic-derm-podcast-630
Pharmacy Times Continuing Education™ (PTCE) provides industry leading pharmacy CE to retail, oncology, managed care, specialty, and health-system pharmacists. They use multiple deliverables in the live, virtual, on-demand, and print formats created by in-house pharmacists to deliver tailored multispecialty  education.
Educational Objectives
Review patient barriers that impact optimal treatment of patients with atopic dermatitis (AD) who are seeking OTC care
List strategies to individualize patient care and improve recommendations for AD
Moderator:
Mary Bridgeman, PharmD, BCPS, BCGP
Clinical Professor
Ernest Mario School of Pharmacy
Rutgers, The State University of New Jersey
Piscataway, New Jersey
 
Internal Medicine Clinical Pharmacist
Robert Wood Johnson University Hospital
New Brunswick, New Jersey
 
Faculty & Caregiver:
Ashley Ellis, PharmD, MBA, CDECS
ImPAcT Director & Assistant Professor
The University of Tennessee Health Science Center
Department of Clinical Pharmacy and Translation Science College of Pharmacy
Memphis, Tennessee
 
Mary Bridgeman, PharmD, BCPS, BCGP, has no financial relationships with commercial interests to disclose.
Ashley Ellis, PharmD, MBA, CDECS, has the following financial relationships with commercial interests to disclose:
Grant/Research Support: Researcher AHRQ “Tennessee Heart Health Network” funding in form of salary release dollars
Consultant: Global Parents for Eczema Research, Continuing Education Alliance, McGraw Hill
 
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hour (0.05 CEU) under the ACPE universal activity numbers 0290-0000-23-268-H01-P and 0290-0000-23-268-H01-T. The activity is available for CE credit through June 30, 2024.
This activity is supported by an educational grant from CeraVe and La Roche-Posay.
Brought to you in partnership with the National Eczema Association.

The New Surescripts CEO Frank Harvey - One Year Later | UnScripted by Surescripts

https://surescripts.com/news-center/press-releases/detail/surescripts-names-frank-harvey-as-new-ceo-to-lead-company-through-continued-growth-and-new-opportunities-to-impact-healthcareARLINGTON, Va. – June 6, 2022 – Surescripts, the nation's leading health information network, has appointed Frank Harvey as Chief Executive Officer, effective June 27. Harvey succeeds Tom Skelton, who previously announced his decision to retire.
Harvey is a pharmacist and an experienced chief executive and investor and has held numerous senior leadership roles during his more than 35-year career in the healthcare technology, pharmacy and pharmaceutical sectors. Harvey joins Surescripts from ATLS Investments, LLC. where he led private equity investing in healthcare technology companies. Previously, Harvey served as Chief Executive Officer of Mirixa Corporation and Liberty Medical Supply, Inc.
“It’s been a pleasure to work closely with Tom over the past eight years, and we appreciate the many successes that Surescripts achieved under his leadership,” explained Steven Miller, MD, Co-Chair of Surescripts’ Board of Directors. “We are now poised for continued growth and new opportunities with Frank’s leadership at this incredible time in healthcare.”
“Frank is a results-oriented leader with strong operational skills, and extensive experience growing healthcare businesses,” said Douglas Hoey, Co-Chair of Surescripts’ Board of Directors. “Frank combines his unique perspective and depth of experience with a passion for improving the lives of patients and evolving the healthcare system.”
“I’m honored to join Surescripts at such a critical time, and I look forward to working with the team to realize the enormous potential we have to change healthcare,” Harvey shared. “I’m committed to what we do as a company and the new products and services we will bring to market that I believe will have a significant impact on the healthcare system as a whole.”

Academic Detailing, Opioid Safety and the Pharmacist | University of Illinois Chicago School of Pharmacy

We thought it would be beneficial to have a brief introduction to the concept of acadmic detailing (AD) and the evidence that supports AD. We also would like to briefly discuss our group (IL ADVANCE). We would introduce the structure of an AD visit leading into the specific opioid safety program for pharmacists. After identifying our topics we thought we could get into more detail about a couple, specifically special populations and OUD. We then would move on to the benefits of AD for the community pharmacist. We could then get into more detail about the IL ADVANCE team and the process for developing content.  Next would be conclusions and wrap up.

Community Pharmacy: Planning for New Profits in 2024 | Happier At Home PRN

Debbie Marcello - host of Happier at Home PRN and Todd Eury, CEO of the Pharmacy Podcast Network welcome DiversifyRx founder Lisa Fasst, PharmD. Lisa is on a mission to save independent pharmacies. Every pharmacy owner deserves to have a thriving, profitable pharmacy. Lisa became a pharmacy owner for the first time in 2005. She has been helping pharmacy owners improve their profitability and diversify their revenue streams since 2012. Lisa knows what it takes to be a pharmacy badass and started DiversifyRx, Pharmacy Badass University, and the Pharmacy Profit Summit to help every pharmacy owner create the pharmacy of their dreams.

Drug Shortages with CDR Emily Thakur | Q&A with FDA

In this podcast series, we answer some of the most frequently asked questions we’ve received from the public.

Insights into the (GCT) Gene/Cell Therapy market & challenges facing market entrants and commercialization | Ascella Health

Continuing advances in cell and gene therapy (CGT) are transforming the pharmacy and point of care ecosystem. Recent launches of new CGTs have yielded mixed results on getting the right therapy to the right patients.  The CGTs pipeline and approvals are likely to rise dramatically in the near future. In 2024 alone, up to 21 cell therapy launches and as many as 31 gene therapy launches are on the horizon. Therefore, the launch readiness for these products should be effective so that the therapies can benefit as many patients as possible while ensuring a sufficient return on manufacturers’ investments. With so many new CGTs poised for commercialization, it’s imperative to consider innovative ways for a product launch that benefits CGTs patients. Ensuring that the market, the product, and the company itself are fully prepared for an effective launch will enable success.
 
Podcast Participants: Michelle Rice, CEO, Michelle Rice & Associates
Kenneth Mankowski, DO, FACN, MS Neurologist Specialist, CNS & MS InstituteHost: 
Michael Baldzicki
 

TWIRx | Operation Prescription Hustle

Meet Scott Fichter, Head Trainer and Creator of No Slack Just Hustle. Scott is a former collegiate athlete, head high school football coach, and fitness instructor with a passion for helping others reach their health and wellness goals. He knows firsthand the importance of maintaining a healthy lifestyle and how it positively impacts one's performance in the workplace.